MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
OVID — Ovid Therapeutics Inc. Common Stock
NasdaqOvid Therapeutics Inc. Common Stock
$2.36
-0.01(-0.42%)
- O
- 2.36
- H
- 2.46
- L
- 2.34
- V
- 987.13K
⏱️ End-of-day dataAs of Oct 7, 2026
OVID — Latest News & Headlines
8 StoriesWhat's going on in today's after hours session - ChartMill
What's going on in today's after hours session ChartMill
Guggenheim Initiates Ovid Therapeutics at Buy - Yahoo Finance
Guggenheim Initiates Ovid Therapeutics at Buy Yahoo Finance
Guggenheim Initiates Coverage on Ovid Therapeutics (OVID) with B - GuruFocus
Guggenheim Initiates Coverage on Ovid Therapeutics (OVID) with B GuruFocus
Guggenheim Initiates Ovid Therapeutics at Buy - marketscreener.com
Guggenheim Initiates Ovid Therapeutics at Buy marketscreener.com
OVID, Steven Gerard Owad - Obituary - Burlington - BurlingtonToday.com
OVID, Steven Gerard Owad - Obituary - Burlington BurlingtonToday.com
OVID Initiates Coverage by Guggenheim - Rating Set to Buy - GuruFocus
OVID Initiates Coverage by Guggenheim - Rating Set to Buy GuruFocus
OVID Initiates Coverage On Guggenheim -- Rating Set to Buy - GuruFocus
OVID Initiates Coverage On Guggenheim -- Rating Set to Buy GuruFocus
Guggenheim starts Ovid Therapeutics with a Buy on OV329 potential - TipRanks
Guggenheim starts Ovid Therapeutics with a Buy on OV329 potential TipRanks